Literature DB >> 8522137

Gavaserin and saltavalin, new peptide antibiotics produced by Bacillus polymyxa.

B Pichard1, J P Larue, D Thouvenot.   

Abstract

A strain of Bacillus polymyxa (BPl), isolated from cauliflower seeds, inhibited the growth of microbial phytopathogens. Growth of this strain in liquid medium containing lactose, ammonium sulfate, biotin, and amino acids, resulted in optimal inhibition in vitro. Two new antibacterial substances were isolated and purified from culture broth. Their molecular masses were, respectively, 911 and 903 daltons. The first compound was named gavaserin because it contained glutamic acid, alanine, valine, serine and 2,4-diaminobutyric acid, and octanoic acid. No fatty acid was detected in the second compound, which was named saltavalin because it contained serine, alanine, leucine, threonine, valine, and 2,4-diaminobutyric acid.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8522137     DOI: 10.1111/j.1574-6968.1995.tb07887.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  15 in total

1.  The genome of the plant growth-promoting rhizobacterium Paenibacillus polymyxa M-1 contains nine sites dedicated to nonribosomal synthesis of lipopeptides and polyketides.

Authors:  Ben Niu; Christian Rueckert; Jochen Blom; Qi Wang; Rainer Borriss
Journal:  J Bacteriol       Date:  2011-10       Impact factor: 3.490

2.  Characterization of biosynthetic enzymes for ectoine as a compatible solute in a moderately halophilic eubacterium, Halomonas elongata.

Authors:  H Ono; K Sawada; N Khunajakr; T Tao; M Yamamoto; M Hiramoto; A Shinmyo; M Takano; Y Murooka
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

3.  Isolation and partial characterization of antibacterial lipopeptide produced by Paenibacillus polymyxa HKA-15 against phytopathogen Xanthomonas campestris pv. phaseoli M-5.

Authors:  Vellaichamy Mageshwaran; Suresh Walia; Kannepalli Annapurna
Journal:  World J Microbiol Biotechnol       Date:  2011-09-25       Impact factor: 3.312

4.  Use of PCR-targeted mutagenesis to disrupt production of fusaricidin-type antifungal antibiotics in Paenibacillus polymyxa.

Authors:  Jingru Li; Perrin K Beatty; Saleh Shah; Susan E Jensen
Journal:  Appl Environ Microbiol       Date:  2007-03-30       Impact factor: 4.792

5.  Biocontrol of Fusarium wilt disease in tomato by Paenibacillus ehimensis KWN38.

Authors:  Kyaw Wai Naing; Xuan Hoa Nguyen; Muhammad Anees; Yong Seong Lee; Yong Cheol Kim; Sang Jun Kim; Myung Hee Kim; Yong Hwan Kim; Kil Yong Kim
Journal:  World J Microbiol Biotechnol       Date:  2014-11-11       Impact factor: 3.312

6.  Gene cluster analysis for the biosynthesis of elgicins, novel lantibiotics produced by Paenibacillus elgii B69.

Authors:  Yi Teng; Wenpeng Zhao; Chaodong Qian; Ou Li; Liang Zhu; Xuechang Wu
Journal:  BMC Microbiol       Date:  2012-03-26       Impact factor: 3.605

7.  Paenimacrolidin, a novel macrolide antibiotic from Paenibacillus sp. F6-B70 active against methicillin-resistant Staphylococcus aureus.

Authors:  Xue-Chang Wu; Chao-Dong Qian; Hai-Huan Fang; Yan-Ping Wen; Jian-Ying Zhou; Zha-Jun Zhan; Rui Ding; Ou Li; Haichun Gao
Journal:  Microb Biotechnol       Date:  2010-08-19       Impact factor: 5.813

Review 8.  Genome mining: Prediction of lipopeptides and polyketides from Bacillus and related Firmicutes.

Authors:  Gajender Aleti; Angela Sessitsch; Günter Brader
Journal:  Comput Struct Biotechnol J       Date:  2015-03-24       Impact factor: 7.271

9.  Production and characterization of a new antibacterial peptide obtained from Aeribacillus pallidus SAT4.

Authors:  Syed Aun Muhammad; Safia Ahmed
Journal:  Biotechnol Rep (Amst)       Date:  2015-09-21

10.  Polymyxin P is the active principle in suppressing phytopathogenic Erwinia spp. by the biocontrol rhizobacterium Paenibacillus polymyxa M-1.

Authors:  Ben Niu; Joachim Vater; Christian Rueckert; Jochen Blom; Maik Lehmann; Jin-Jiang Ru; Xiao-Hua Chen; Qi Wang; Rainer Borriss
Journal:  BMC Microbiol       Date:  2013-06-18       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.